---
title: "Imatinib - Chronic Phase Chronic Myeloid Leukemia"
sidebar: mydoc_sidebar
permalink: db00619-mesh-d015466-1.html
toc: false 
---


Path ID: `DB00619_MESH_D015466_1`
{% include image.html url="images/db00619-mesh-d015466-1.png" file="db00619-mesh-d015466-1.png" alt="db00619-mesh-d015466-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000068877">MESH:D000068877 </a> | imatinib | Drug |
| <a href="https://identifiers.org/MESH:D016044">MESH:D016044 </a> | Fusion Proteins, bcr-abl | Protein |
| <a href="https://identifiers.org/GO:0004674">GO:0004674 </a> | protein serine/threonine kinase activity | MolecularActivity |
| <a href="https://identifiers.org/GO:0007266">GO:0007266 </a> | Rho protein signal transduction | BiologicalProcess |
| <a href="https://identifiers.org/GO:0008283">GO:0008283 </a> | cell population proliferation | BiologicalProcess |
| <a href="https://identifiers.org/GO:0006915">GO:0006915 </a> | apoptotic process | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D015466">MESH:D015466 </a> | Chronic phase chronic myeloid leukemia | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Imatinib | DECREASES ACTIVITY OF | Fusion Proteins, Bcr-Abl |
| Fusion Proteins, Bcr-Abl | POSITIVELY REGULATES | Protein Serine/Threonine Kinase Activity |
| Protein Serine/Threonine Kinase Activity | POSITIVELY CORRELATED WITH | Rho Protein Signal Transduction |
| Rho Protein Signal Transduction | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Rho Protein Signal Transduction | NEGATIVELY CORRELATED WITH | Apoptotic Process |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Chronic Phase Chronic Myeloid Leukemia |
| Apoptotic Process | NEGATIVELY CORRELATED WITH | Chronic Phase Chronic Myeloid Leukemia |
|---------|-----------|---------|

Comment: Imatinib also modulates other protein targets and is an indication for other malignancies (https://en.wikipedia.org/wiki/Imatinib#Medical_uses).

Reference: 
  - [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate)
  - [https://go.drugbank.com/drugs/DB00619#mechanism-of-action](https://go.drugbank.com/drugs/DB00619#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Imatinib#Chronic_myelogenous_leukemia](https://en.wikipedia.org/wiki/Imatinib#Chronic_myelogenous_leukemia)
